Rafferty Asset Management Increases Stake in CVS Health

Institutional investor adds 7,077 shares to its CVS Health holdings in Q3 2025.

Mar. 2, 2026 at 4:55pm

Rafferty Asset Management LLC increased its stake in CVS Health Corporation (NYSE:CVS) by 5.3% in the third quarter of 2025, according to the company's 13F filing with the Securities and Exchange Commission. The fund now owns 140,792 shares of the pharmacy operator's stock, worth $10,614,000 as of the most recent SEC filing.

Why it matters

This transaction highlights the continued institutional investor interest in CVS Health, one of the largest pharmacy chains and healthcare companies in the United States. Rafferty Asset Management's increased stake suggests the firm sees long-term growth potential in CVS Health's diversified business model spanning retail pharmacies, pharmacy benefit management, and healthcare services.

The details

Rafferty Asset Management acquired an additional 7,077 shares of CVS Health in the third quarter, bringing its total position to 140,792 shares. This represents a 5.3% increase in the firm's stake in the company. CVS Health's stock price has fluctuated between $58.35 and $85.15 over the past 52 weeks, closing at $79.74 on Monday.

  • Rafferty Asset Management increased its CVS Health stake in Q3 2025.

The players

Rafferty Asset Management LLC

An institutional investment management firm that has increased its stake in CVS Health Corporation.

CVS Health Corporation

A diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services, and health care solutions.

Got photos? Submit your photos here. ›

The takeaway

Rafferty Asset Management's increased investment in CVS Health reflects the firm's confidence in the company's ability to navigate the evolving healthcare landscape and capitalize on growth opportunities in its pharmacy, pharmacy benefit management, and healthcare services businesses.